Cartesian Therapeutics, Inc.
Descartes-08
myositis
Date
TBD
FDA decision · Date TBD estimated
What's at stake
An FDA complete response letter on Descartes-08 for myositis is in focus around Date TBD.
Primary source
· SEC 8-K
verified 13h ago
“evaluate clinical data from a subset of patients from the trial in the first half of 2027 to determine the path to a pivotal trial in these indications”